| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/30/1998 | WO1998017284A2 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy |
| 04/30/1998 | WO1998017283A1 Method of vaccinating infants against infections |
| 04/30/1998 | WO1998011225A3 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | WO1997048795A3 Compositions and methods for treating specific gene expression-related diseases and disorders in humans |
| 04/30/1998 | DE19746362A1 Production of nucleic acid conjugates |
| 04/30/1998 | DE19644500A1 AAV-DNA mit Helfervirus-Sequenzen AAV DNA having helper virus sequences |
| 04/30/1998 | CA2751712A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2745736A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2271721A1 Mini-e1a genes and gene products |
| 04/30/1998 | CA2270154A1 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 04/30/1998 | CA2269825A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 04/30/1998 | CA2269754A1 Dna vaccines for herpes simplex virus 1 and 2 |
| 04/30/1998 | CA2269644A1 Inhibiting hiv infection by cleaving co-receptor rna |
| 04/30/1998 | CA2269444A1 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates |
| 04/30/1998 | CA2269349A1 Mucin-mediated immunomodulation |
| 04/30/1998 | CA2269100A1 Methods and compositions for delivery and expression of interferon-.alpha. nucleic acids |
| 04/30/1998 | CA2269074A1 Immunotherapy and improved vaccines |
| 04/30/1998 | CA2269034A1 Use of fasl or fasl transfected cd4+/fasl-/th1-cell lines for the treatment of th1/th2 diseases |
| 04/30/1998 | CA2268949A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 04/30/1998 | CA2268804A1 Composition containing chitosan |
| 04/30/1998 | CA2268752A1 Plasmids encoding immunogenic proteins and intracellular as follows |
| 04/30/1998 | CA2268751A1 Fringe proteins and notch signalling |
| 04/30/1998 | CA2268749A1 Structural and functional conservation of the c. elegans clock gene clk-1 |
| 04/30/1998 | CA2268742A1 Multi-functional chimeric hematopoietic receptor agonists |
| 04/30/1998 | CA2268720A1 Induction of rev and tat specific cytotoxic t-cells for prevention and treatment of human immunodeficiency virus (hiv) infection |
| 04/30/1998 | CA2268476A1 Use of hyaluronan in gene therapy |
| 04/30/1998 | CA2268365A1 Il-12 gene expression and delivery systems and uses |
| 04/30/1998 | CA2268276A1 Gene expression and delivery systems and uses |
| 04/30/1998 | CA2268271A1 Lentiviral vectors |
| 04/30/1998 | CA2268045A1 Polypeptides comprising gax protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acids and their use |
| 04/30/1998 | CA2267636A1 Retroviral vectors |
| 04/29/1998 | EP0838526A1 Human satellite microchromosomes as vectors for gene therapy |
| 04/29/1998 | EP0838524A2 RsbV-1 derived from Staphylococcus |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0837952A2 Detection and quantification of human herpesvirus 7 by enzymatic amplification of virus dna |
| 04/29/1998 | EP0837951A1 Antisense inhibition of hepatitis b virus replication |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837936A1 New immunoregulatory protein lst-1 |
| 04/29/1998 | EP0837934A1 Human vascular endothelial growth factor 2 |
| 04/29/1998 | EP0837933A1 Optimized minizymes and miniribozymes and uses thereof |
| 04/29/1998 | EP0837929A2 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 04/29/1998 | EP0837928A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 04/29/1998 | EP0837699A1 Immunovectors for the intracellular and intranuclear transport |
| 04/29/1998 | EP0837629A1 Pericardial therapeutic and diagnostic agent delivery |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1179981A Acupuncture medium induction gene transfer-gene needle |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744625 Cationic transport reagents |
| 04/28/1998 | US5744456 Vector contining promoter and gene |
| 04/28/1998 | US5744362 Antisense oligonucleotide modulation of raf gene expression |
| 04/28/1998 | US5744347 Excising; detaching from membrane; collecting cells displaying a particular phenotype capable of giving rise to blood cells |
| 04/28/1998 | US5744338 DNA encoding seryl tRNA synthetase from Staphylococcus aureus |
| 04/28/1998 | US5744327 Methods for producing insulin in response to non-glucose secretagogues |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744304 Introducing into cell vector including selected protein gene under control of heterologous inflammation responsive promoter, contacting with cytokine which activates gene to express protein |
| 04/28/1998 | US5744159 Plasmid entrapping multilamellar liposomes |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744141 Flavivirus recombinant poxvirus immunological composition |
| 04/28/1998 | US5744140 Recombinant poxvirus containing forein dna from encephalitis virus protein m or virus protein e, ns1, and ns2a |
| 04/23/1998 | WO1998016918A1 Method for recovering data from disk with magneto-resistive head in presence of thermal asperities |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016641A1 Isolation and method of using tissue growth-inducing frzb protein |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016250A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 04/23/1998 | WO1998016246A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | WO1998016202A2 Fusogenic liposome composition and method |
| 04/23/1998 | WO1998009657A3 Method for recombinant adeno-associated virus-directed gene therapy |
| 04/23/1998 | WO1998009170A3 Methods and compositions for the detection of cervical cancer |
| 04/23/1998 | WO1998006753A3 P53 mutant |
| 04/23/1998 | WO1998004702A3 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 04/23/1998 | DE19643093A1 Verwendung von FasL oder mit FasL transfizierten CD4+/FasL-/TH1-Zellinien zur Behandlung von TH1/TH2-Krankheiten, Verfahren zur Herstellung von CD4+/FasL+/TH1-Zellinien und Stoffzusammensetzungen von FasL und einem oder mehren Cytokinen sowie dessen Verwendung zur Behandlung von TH1/TH2-Krankheiten Use of FasL or FasL transfected CD4 + / FasL / TH1 cell lines for the treatment of Th1 / Th2 diseases, processes for the production of CD4 + / FasL + / TH1-cell lines and compositions of FasL and to one or more cytokines, as well as its use for the treatment of Th1 / Th2 diseases |
| 04/23/1998 | CA2268008A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | CA2267977A1 Cytokine enhanced immunotherapy for brain tumors |
| 04/23/1998 | CA2267110A1 Fanconi gene i |
| 04/22/1998 | EP0837138A2 Novel topoisomerase III |
| 04/22/1998 | EP0837137A2 Novel topoisomerase III |
| 04/22/1998 | EP0837136A2 Novel topoisomerase I |
| 04/22/1998 | EP0837133A2 DNA strand resolution proteins of the resolvase family |
| 04/22/1998 | EP0837127A2 Hereditary multiple exostose gene, Ext2 |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0836648A1 Recombinant mva virus, and the use thereof |
| 04/22/1998 | EP0836647A2 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/22/1998 | EP0836645A1 Dry powder formulations of polynucleotide complexes |
| 04/22/1998 | EP0836643A1 Immunoprotective barrier for transplantation of cells |
| 04/22/1998 | EP0836484A1 In vitro packaging of adeno-associated virus dna |
| 04/22/1998 | EP0836481A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
| 04/22/1998 | EP0661933B1 Morphogen-enriched dietary composition |
| 04/22/1998 | CN1179470A Nucleic acid constructs containing hybrid promoters for use in gene therapy |
| 04/21/1998 | US5741685 Parenchymal cells packaged in immunoprotective tissue for implantation |
| 04/21/1998 | US5741683 Transduction of mammal cells and gene therapy |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741673 Nucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/16/1998 | WO1998015639A1 Method for preparing compositions for transferring nucleic acids |
| 04/16/1998 | WO1998015636A1 Alphavirus-retrovirus vectors |
| 04/16/1998 | WO1998015635A2 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine |
| 04/16/1998 | WO1998015634A1 Mammary gland-specific promoters |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |